Literature DB >> 22423020

Human papillomavirus vaccine and pregnancy.

Andrea Narducci1, Adrienne Einarson, Pina Bozzo.   

Abstract

UNLABELLED: QUESTION A: patient of mine who recently learned she was 6 weeks pregnant had received the recombinant human papillomavirus (HPV) quadrivalent vaccine at 4 weeks of gestation. She is quite worried about how this will affect her baby. What is known about the safety of the HPV vaccine during pregnancy? ANSWER: The HPV vaccine is generally not recommended for use in pregnant women. However, theoretically, because it is not a live vaccine, it is not expected to be associated with an increased risk. Also, information from the manufacturer's pregnancy registry and phase 3 clinical trials does not indicate an increased risk of fetal malformations or other adverse effects due to the vaccine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22423020      PMCID: PMC3303646     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception.

Authors:  P L Hermonat; S Kechelava; C L Lowery; S Korourian
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

2.  Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials.

Authors:  Sholom Wacholder; Bingshu Eric Chen; Allen Wilcox; George Macones; Paula Gonzalez; Brian Befano; Allan Hildesheim; Ana Cecilia Rodríguez; Diane Solomon; Rolando Herrero; Mark Schiffman
Journal:  BMJ       Date:  2010-03-02

3.  Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials.

Authors:  Suzanne M Garland; Kevin A Ault; Stanley A Gall; Jorma Paavonen; Heather L Sings; Karen L Ciprero; Alfred Saah; Deborah Marino; Desmond Ryan; David Radley; Haiping Zhou; Richard M Haupt; Elizabeth I O Garner
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

4.  Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine.

Authors:  Adrian Dana; Karyn M Buchanan; Mary Ann Goss; Margaret M Seminack; Kristine E Shields; Scott Korn; Michael L Cunningham; Richard M Haupt
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

5.  Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood.

Authors:  M Puranen; M Yliskoski; S Saarikoski; K Syrjänen; S Syrjänen
Journal:  Am J Obstet Gynecol       Date:  1996-02       Impact factor: 8.661

6.  Placental infection with human papillomavirus is associated with spontaneous preterm delivery.

Authors:  L M Gomez; Y Ma; C Ho; C M McGrath; D B Nelson; S Parry
Journal:  Hum Reprod       Date:  2008-01-08       Impact factor: 6.918

  6 in total
  2 in total

1.  Why, when and for what diseases pregnant and new mothers "should" be vaccinated.

Authors:  Giovanni Gabutti; Giorgio Conforti; Alberto Tomasi; Parvanè Kuhdari; Paolo Castiglia; Rosa Prato; Silvia Memmini; Chiara Azzari; Giovanni Vitali Rosati; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 2.  Maternal HPV Infection: Effects on Pregnancy Outcome.

Authors:  Carmen Elena Condrat; Lidia Filip; Mirela Gherghe; Dragos Cretoiu; Nicolae Suciu
Journal:  Viruses       Date:  2021-12-07       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.